WISAM 2018 Webinar Series: Treatment of Substance Use Disorders in Primary Care
Overview: This complimentary, four-part webinar series, funded in part through a Wisconsin Medical Society Foundation grant, provides timely information and updates related to the treatment of substance use disorders. All presenters are local experts with a clear understanding of Wisconsin’s rural issues and barriers to care.
Target audience: Primary care providers in rural areas of Wisconsin who receive little support and education for evidence-based treatment of substance use disorders.
Participation: Online registration is required. Participants may attend any or all of the webinar sessions either in-person (at Meriter Hospital in Madison on the date/time indicated), or through the on-demand webinar option after the session have been recorded.
Part 1: Wednesday, June 20, 2018, 5:30-6:30 pm
Topic: Suboxone 2.0: Beyond the Basics, presented by Ritu Bhatnagar, MD
Learning Objectives: Describe ways to talk non-judgmentally about adherence and sensitive issues related to buprenorphine; Develop strategies for ongoing management of patients on buprenorphine in the primary care setting.
Part 2: Wednesday, July 18, 2018; 5:30-6:30 pm
Topic: Interpretation of Urine Drug Screen, presented by David Galbis-Reig, MD
Learning Objectives: Discuss the history of drug testing and its introduction into clinical practice; Describe the different drug testing matrices and the potential advantages and disadvantages of each in clinical practice; Understand the basics of urine drug testing: What to test, how to test, and in what situations to perform a urine drug screen; Understand the limitations of urine drug testing; Understand how to interpret a positive urine immunoassay and when to obtain confirmatory tests.
Part 3: Wednesday, August 15, 2018, 5:30-6:30 pm
Topic: Treatment of Stimulant Disorder, presented by Mark Lim, MD
Learning Objectives: Discuss appropriate treatment strategies for patients with stimulant disorder; Understand the limitations of combination pharmacotherapies for the management of stimulant disorder.
Part 4: Wednesday, October 17, 2018; 5:30-6:30 pm
Topic: Treatment of Alcohol Use and Opioid Use Disorder in Pregnancy, presented by Jacquelyn Adams, MD
Learning Objectives: Describe opioid use disorder and alcohol use disorder in pregnancy; Understand risks of withdrawal in pregnancy; Discuss current treatment standards and possible new therapies specific to pregnancy.